The U.S. Food and Drug Administration (FDA) has released a preliminary guidance for manufacturers on premarket submissions for surgical medical devices that incorporate robotic technologies.
Issued in late September, the draft guidance, titled “Robotically-Assisted Surgical Devices-Premarket Submissions,” offers device manufacturers recommendations on non-clinical testing, clinical data, and labeling associated with certain robotically-assisted surgical devices (RASDs).
Specific devices included under the scope of the guidance include “teleoperated, software-controlled systems that integrate robotic technologies and subassemblies,” that are “designed to assist qualified practitioners in precisely positioning and controlling one or more surgical instruments…”
A reminder that guidance documents issued by the FDA solely reflect the FDA’s current thinking and are intended to promote consistency in premarket submissions filed by device manufacturers.
Read the FDA’s draft guidance on premarket submissions for robotically-assisted surgical devices.
Comments can be submitted through November 24th (reference FDA Docket ID FDA-2026-N-9505-0001).
